MIMEDX GROUP, INC.
Company Stats
- Market Cap
- $679.2M
- as of Sep 30, 2026
- Shares Outstanding
- 145.8M
- Free Float
- 67.9%
Income Statement
- Revenue
- $418.6M
- Operating Income
- $63.9M
- Net Income
- $48.6M
- EBITDA
- $78.8M
- Revenue Growth, 3Y
- 16.1%
- FCF Margin, 3Y Avg
- 14.8%
- FCF Margin, Worst Year
- 7.7%
Cash Flow
- Free Cash Flow
- $74.0M
- FCF Yield
- 10.9%
- Owner FCF Yield
- 8.5%
Balance Sheet
- Cash & Equivalents
- $166.1M
Returns & Capital
- Buyback Yield, 3Y Avg
- 0.5%
- SBC, 3Y Avg
- $16.8M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $418.6M | $74.0M | 17.7% |
| FY2024 | $348.9M | $66.2M | 19.0% |
| FY2023 | $321.5M | $24.8M | 7.7% |
| FY2022 | $267.8M | -$19.4M | -7.2% |
| FY2021 | $242.0M | -$5.2M | -2.1% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 28, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back
MiMedx to Buy Sanara MedTech in $350 Million Cash-and-Stock Deal